Industry Influence in Medical Research
-
Darts & Letters EP12: Left Jab (w/ Garth Mullins of CRACKDOWN)
More...On a vaccine rollouts in an age of distrust, with widening socioeconomic inequality.
-
The Heroin Clinic (Rebroadcast)
More...At Crosstown Clinic, doctors are turning addiction treatment on its head: they’re prescribing heroin-users the very drug they’re addicted to. This is the story of one clinic’s quest to remove the harms of addiction, without removing the addiction itself.
-
Secondary Symptoms #7: Medical Imaginaries
More...Our whirlwind tour of the pharmaceutical industry ends this week. We’ve shown you the dysfunction, now we look for a better way. We look at ways we can fundamentally change the industry, and medicine itself.
-
Secondary Symptoms #6: Pandemic Fat Cats
More...There’s another coronavirus. This one, causing horrific swelling in cats, even killing them. Gilead Pharmacueticals might have a drug that can cure this feline coronavirus. Yet, they’re not sharing that drug, possibly because they’re scared it might harm their chances with another drug: Remdesivir. You may have heard of it; it’s the supposed ‘gold standard’ of care for COVID-19. The story of Remdesivir (and of the black market cat drug sibling) reveals how pharmaceutical companies do their research, and the lengths they go to protect their profits.
-
On the Limitations of Evidence-Based Medicine
More...Is Evidence-Based Medicine a ‘Gold Standard,’ or a political tool?
-
-
-
#6: The Tamiflu Trials
More...Medical experts are rushing to see which drugs might help treat COVID-19. There are dozens of candidates: Remdesivir, Hydroxycloroquin, Actemra, Kevzara, Favipiravir, the list goes on. They better pick the right one; because billions of dollars of public money is at stake, not to mention 100s of thousands — if not millions — of lives.